Hyperliquid Strategies Inc (PURR) Stock Analysis

Hyperliquid Strategies held approximately 29.4 million HYPE tokens as of August 23, 2026 — which it describes as the largest HYPE treasury of any U.S. public company — funded by roughly $299.9 million in Closing PIPE proceeds and 12.5 million HYPE tokens contributed at its December 2025 business combination with Sonnet BioTherapeutics. The company stakes substantially all of its HYPE holdings on the Hyperliquid network, and its primary regulatory exposure runs through digital-asset securities and money-transmitter law rather than a bank or insurance regulator.

Hyperliquid Strategies generates value primarily through the appreciation of its HYPE token holdings and through staking rewards, which accrue at an annualized rate — approximately 2.17% to 2.19% as of August 23, 2026 — calculated inversely to the total HYPE staked across the network and paid in additional HYPE. The company follows a three-pillar Treasury Strategy Policy covering capital raising (equity issuance when shares trade above net asset value, via an Equity Facility with capacity for up to $1.0 billion of common stock), capital allocation (a working capital reserve, a cash reserve, and core HYPE holdings), and capital deployment (buying HYPE when it is undervalued and repurchasing its own stock when shares trade at a discount to net asset value). Rorschach Advisors LLC, the entity that contributed the founding HYPE treasury, holds board nomination rights — including the right to name the Chairman — for as long as it retains at least 10% of the shares it held at closing, and is entitled to equity grants tied to future financings.